Literature DB >> 19092281

Surgical treatment of hepatocellular carcinoma: comparison of resection and transplantation.

Yasuhiko Sugawara1, Norihiro Kokudo.   

Abstract

The treatment of hepatocellular carcinoma (HCC) has progressed remarkably over the last years. In patients with good hepatic functional reserve, liver resection should be considered as the therapeutic modality for local control of primary HCC, including a large tumor, or multiple HCCs with vascular invasion. Anatomic resection involves systematic elimination of the main tumor and its minute metastases. In cases with poor hepatic functional reserve, however, liver transplantation may be a better therapeutic option depending on patient age and tumor-related factors. Patients with tumors satisfying the Milan criteria (or its extended criteria) are good candidates for liver transplantation. We analyzed the findings from 100 patients with HCC who underwent living donor liver transplantation. The overall survival at 3 and 5 years after liver transplantation was 79 and 78%, respectively, with a median follow-up of 45 months. The treatment algorithm, based on evidence accrued from published papers, is now available and is useful for determining the therapeutic choice based on the tumor- and liver function-related conditions. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2008        PMID: 19092281     DOI: 10.1159/000173433

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


  3 in total

1.  Resection of lung metastases from hepatocellular carcinoma after living donor liver transplantation: report of two cases.

Authors:  Junichi Togashi; Yasuhiko Sugawara; Taku Aoki; Sumihito Tamura; Junichi Kaneko; Jun Nakajima; Atsushi Sano; Norihiro Kokudo
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

2.  Intermittent hepatic inflow occlusion during partial hepatectomy for hepatocellular carcinoma does not shorten overall survival or increase the likelihood of tumor recurrence.

Authors:  Jiwei Huang; Wei Tang; Roberto Hernandez-Alejandro; Kimberly A Bertens; Hong Wu; Mingheng Liao; Jiaxin Li; Yong Zeng
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

Review 3.  Role of pre-transplant 18F-FDG PET/CT in predicting hepatocellular carcinoma recurrence after liver transplantation.

Authors:  Onur Yaprak; Sencan Acar; Gokhan Ertugrul; Murat Dayangac
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.